Zevra Therapeutics (ZVRA) Current Assets (2014 - 2026)
Zevra Therapeutics (ZVRA) recorded Current Assets of $251.3 million in Q2 2026, up 11.0% from $226.34 million a year earlier and up 9.3% from the prior quarter.
Zevra Therapeutics (ZVRA) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics reported Current Assets of $223.01 million, up 159.2% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 92.7% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $86.03 million in FY2024 (-1.0%), $86.94 million in FY2023 (-6.4%), $92.83 million in FY2022 (-19.3%) and $115.06 million in FY2021.
- The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2014.
- On a year-over-year basis, Current Assets has increased for six consecutive quarters, with growth averaging 93.9% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 271.7% in Q2 2025, against a decline of 41.1% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $229.97 million (Q1 2026), $223.01 million (Q4 2025) and $225.12 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn | 251.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 251.30 Mn |
| Mar 31, 2026 | 229.97 Mn |
| Dec 31, 2025 | 223.01 Mn |
| Sep 30, 2025 | 225.12 Mn |
| Jun 30, 2025 | 226.34 Mn |
| Mar 31, 2025 | 81.57 Mn |
| Dec 31, 2024 | 86.03 Mn |
| Sep 30, 2024 | 99.44 Mn |
| Jun 30, 2024 | 60.89 Mn |
| Mar 31, 2024 | 62.89 Mn |
| Dec 31, 2023 | 86.94 Mn |
| Sep 30, 2023 | 137.01 Mn |
| Jun 30, 2023 | 103.43 Mn |
| Mar 31, 2023 | 104.28 Mn |
| Dec 31, 2022 | 92.83 Mn |
| Sep 30, 2022 | 85.13 Mn |
| Jun 30, 2022 | 87.44 Mn |
| Mar 31, 2022 | 105.78 Mn |
| Dec 31, 2021 | 115.06 Mn |
| Sep 30, 2021 | 134.63 Mn |
Zevra Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();